These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17919178)

  • 1. Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes.
    Tarasov AI; Girard CA; Larkin B; Tammaro P; Flanagan SE; Ellard S; Ashcroft FM
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():46-55. PubMed ID: 17919178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
    Girard CA; Shimomura K; Proks P; Absalom N; Castano L; Perez de Nanclares G; Ashcroft FM
    Pflugers Arch; 2006 Dec; 453(3):323-32. PubMed ID: 17021801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue.
    Shimomura K; de Nanclares GP; Foutinou C; Caimari M; Castaño L; Ashcroft FM
    Diabet Med; 2010 Feb; 27(2):225-9. PubMed ID: 20546268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
    Proks P; Girard C; Baevre H; Njølstad PR; Ashcroft FM
    Diabetes; 2006 Jun; 55(6):1731-7. PubMed ID: 16731836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
    Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
    Shimomura K; Girard CA; Proks P; Nazim J; Lippiat JD; Cerutti F; Lorini R; Ellard S; Hattersley AT; Barbetti F; Ashcroft FM
    Diabetes; 2006 Jun; 55(6):1705-12. PubMed ID: 16731833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
    Tammaro P; Girard C; Molnes J; Njølstad PR; Ashcroft FM
    EMBO J; 2005 Jul; 24(13):2318-30. PubMed ID: 15962003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
    Proks P; Antcliff JF; Lippiat J; Gloyn AL; Hattersley AT; Ashcroft FM
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17539-44. PubMed ID: 15583126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.
    Tammaro P; Proks P; Ashcroft FM
    J Physiol; 2006 Feb; 571(Pt 1):3-14. PubMed ID: 16339180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
    Proks P; Girard C; Ashcroft FM
    Hum Mol Genet; 2005 Sep; 14(18):2717-26. PubMed ID: 16087682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
    Craig TJ; Shimomura K; Holl RW; Flanagan SE; Ellard S; Ashcroft FM
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2551-7. PubMed ID: 19351728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
    Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
    Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.
    Proks P; Shimomura K; Craig TJ; Girard CA; Ashcroft FM
    Hum Mol Genet; 2007 Aug; 16(16):2011-9. PubMed ID: 17584766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsing diabetes can result from moderately activating mutations in KCNJ11.
    Gloyn AL; Reimann F; Girard C; Edghill EL; Proks P; Pearson ER; Temple IK; Mackay DJ; Shield JP; Freedenberg D; Noyes K; Ellard S; Ashcroft FM; Gribble FM; Hattersley AT
    Hum Mol Genet; 2005 Apr; 14(7):925-34. PubMed ID: 15718250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk.
    Vedovato N; Cliff E; Proks P; Poovazhagi V; Flanagan SE; Ellard S; Hattersley AT; Ashcroft FM
    Diabetologia; 2016 Jul; 59(7):1430-1436. PubMed ID: 27118464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
    Gloyn AL; Pearson ER; Antcliff JF; Proks P; Bruining GJ; Slingerland AS; Howard N; Srinivasan S; Silva JM; Molnes J; Edghill EL; Frayling TM; Temple IK; Mackay D; Shield JP; Sumnik Z; van Rhijn A; Wales JK; Clark P; Gorman S; Aisenberg J; Ellard S; Njølstad PR; Ashcroft FM; Hattersley AT
    N Engl J Med; 2004 Apr; 350(18):1838-49. PubMed ID: 15115830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy.
    Lin CW; Lin YW; Yan FF; Casey J; Kochhar M; Pratt EB; Shyng SL
    Diabetes; 2006 Jun; 55(6):1738-46. PubMed ID: 16731837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
    Winkler M; Lutz R; Russ U; Quast U; Bryan J
    J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.
    McKay NG; Kinsella JM; Campbell CM; Ashford ML
    Br J Pharmacol; 2000 Jun; 130(4):857-66. PubMed ID: 10864893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.